ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Cumulative incidence of active TB, by latent TB status and risk group

Cumulative incidence of active TB, by latent TB status and risk group
Population/clinical condition Cumulative TB incidence (percent)
Up to 2 years Up to 5 years
Estimate 95% CI Estimate 95% CI
Negative test for LTBI 0.2 0.1 to 0.4 0.3 0.2 to 0.5
Positive test for LTBI, treated 0.7 0.4 to 1.3 1.1 0.6 to 2.0
Positive test for LTBI, NOT treated
All conditions 4.0 2.6 to 6.3 5.4 3.5 to 8.5
Adult contact of a patient with TB 3.7 2.3 to 6.0 4.8 3.0 to 7.7
Migrant 4.1 1.3 to 12.0 5.0 1.6 to 14.5
Immunocompromised 2.4 0.8 to 6.8 4.7 1.5 to 14.3
Child contact of a patient with TB (age <5 years) 26.0 9.4 to 60.1 27.7 10.0 to 63.2
Child contact of a patient with TB (age 5 to 14 years) 12.4 5.7 to 25.6 13.4 13.4 to 27.7
In a systematic review and meta-analysis including 18 studies and 80,468 patients, the cumulative percentage of individuals who developed active TB for up to 5 years was determined based on latent TB test and treatment status[1]. As shown, disease rates were very low in those with negative tests, somewhat higher in those with positive tests received LTBI treatment, and much higher in those with positive tests who were not treated; in addition, disease rates varied depending upon condition and age.
Migrants and close contacts comprised 80% of active TB cases diagnosed among adults within 5 years; among child contacts, more than 90% of active TB cases occurred within 2 years. This emphasizes the need for rapid identification, testing, and treatment of those with LTBI in these groups. This study also underscores the very high rate of disease among children, especially those less than age 5, more than 25% of whom developed active TB in the absence of LTBI treatment.
TB: tuberculosis; IGRA: interferon-gamma release assay; TST: tuberculin skin test; LTBI: latent TB infection.
References:
  1. Gupta RK, Calderwood CJ, Yavlinsky A, et al. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings 2020; Nat Med 26:1941.
Graphic 130579 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟